April 26, 2011 (UPDATED April 29, 2011) — Women without risk factors for venous thromboembolism (VTE) who are taking the third-generation oral contraceptive drospirenone have an increased risk for ...

Boston, MA - Women without risk factors for venous thromboembolism (VTE) who are taking the third-generation oral contraceptive drospirenone have an increased risk for nonfatal VTE compared with women ...

All combined oral contraceptives increase VTE risk. The risk is greater for those containing desogestrel, drospirenone, gestodene (not available in the United States), and cyproterone acetate (not ...

(PhysOrg.com) -- Two new drug safety studies conducted by researchers at Boston University School of Medicine (BUSM) provide strong evidence that women taking oral contraception with drospirenone have ...

A large new study from Denmark provides the best evidence yet obtained that oral contraceptives (OCs) containing newer forms of progestogen (drospirenone, desogestrel, or gestodene) are associated ...

FDA Drug Safety Communication: Safety review update on the possible increased risk of blood clots with birth control pills containing drospirenone [09-26-2011] The U.S. Food and Drug Administration ...

A new study confirms previous findings that certain oral contraceptive pills are more likely to cause serious blood clots than others. A study published online in the British Medical Journal confirms ...

New research has found an increased risk of arterial thrombotic events and venous thromboembolic events -- commonly referred to as blockage of arteries and blood clots, respectively -- associated with ...

Please provide your email address to receive an email when new articles are posted on . When combined with sotalol, the oral contraceptive drospirenone was associated with QTc prolongation, a marker ...

The association between use of oral contraceptives and increased risk of venous thrombosis has long been known, although lowering of the estrogen dose in combined oral contraceptive (COC) preparations ...

Birth control pills containing drospirenone raises blood clots risk in women, finds a study. The study funded by U.S. Food and Drug Administration and led by the Kaiser Permanente Northern California ...

Ethinyl estradiol/drospirenone (Yasmin) 1 tablet daily, to start either on the first day of the menstrual cycle or the first Sunday after the start of the menstrual period 21 active yellow tablets: 30 ...